FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.5  |  FHIR Version n/a  User: [n/a]

1540541000168106: Erlotinib (Apotex) (erlotinib 150 mg) tablet (trade product unit of use)


Status: current, Defined. Date: 30-Apr 2021. Module: Australian Medicines Terminology module

Descriptions:

Id Description Lang Type Status Case? Module
4556361000168114 Erlotinib (Apotex) (erlotinib 150 mg) tablet (trade product unit of use) en Fully specified name Active Case sensitive Australian Medicines Terminology module
4556371000168115 Erlotinib (Apotex) 150 mg tablet en Synonym Active Case sensitive Australian Medicines Terminology module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Erlotinib (Apotex) 150 mg tablet Is a Erlotinib (Apotex) true Inferred relationship Some
Erlotinib (Apotex) 150 mg tablet Is a trade product unit of use true Inferred relationship Some
Erlotinib (Apotex) 150 mg tablet Is a erlotinib 150 mg tablet true Inferred relationship Some
Erlotinib (Apotex) 150 mg tablet has manufactured dose form tablet true Inferred relationship Some
Erlotinib (Apotex) 150 mg tablet has Australian BoSS erlotinib true Inferred relationship Some 1434514234
Erlotinib (Apotex) 150 mg tablet has intended active ingredient erlotinib true Inferred relationship Some 1434514234
Erlotinib (Apotex) 150 mg tablet has unit of use tablet true Inferred relationship Some 37063353

Inbound Relationships Type Active Source Characteristic Refinability Group
Erlotinib (Apotex) 150 mg tablet, 30, blister pack has TPUU True Erlotinib (Apotex) 150 mg tablet Inferred relationship Some 1796786255
Erlotinib (Apotex) 150 mg tablet, 30 has TPUU True Erlotinib (Apotex) 150 mg tablet Inferred relationship Some 170739025

Reference Sets

Trade product unit of use reference set

Back to Start